RLYB - Rallybio Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Rallybio Corp's activity chart (see below) currently has 44 price targets and 45 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.64% with an average time for these price targets to be met of 279.55 days.

Most recent stock forecast was given by from JMP on 23-Apr-2025. First documented stock forecast 23-Aug-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 23-Apr-2025

1 years 4 months 17 days ago
(23-Apr-2025)

9/15 (60%)

$-5.36 (-40.12%)

285

1.89

Buy Since 13-Mar-2024

$20

1 years 4 months 25 days ago
(15-Apr-2025)

1/2 (50%)

$8.4 (72.41%)

29

7.32

Buy Since 23-Aug-2021

$15

1 years 4 months 29 days ago
(11-Apr-2025)

2/2 (100%)

$5.88 (64.47%)

552

1.16

Buy Since 17-Apr-2023

$5

1 years 5 months ago
(09-Apr-2025)

18/18 (100%)

$-0.14 (-2.72%)

105

7.85

Buy Since 09-Dec-2022

$18

2 years 3 months 25 days ago
(15-May-2024)

4/4 (100%)

$-26.8 (-59.82%)

219

Show more analysts

Please expand the browser size to see the chart

What is RLYB (Rallybio Corp) average time for price targets to be met?

On average it took 280 days for the stock forecasts to be reached, with an average price target met ratio of 83.64%.

Which analyst most recently updated their price target on RLYB (Rallybio Corp)?

Which analyst has the most public recommendations on RLYB (Rallybio Corp)?

has 0 price targets and 0 ratings on RLYB

Which analyst is the currently most bullish on RLYB (Rallybio Corp)?

Laura Chico with the highest potential upside of $2.56

Which analyst is the currently most reserved on RLYB (Rallybio Corp)?

Jonathan Wolleben with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?